Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
2013 · Leukemia Research · 192 citations
https://doi.org/10.1016/j.leukres.2013.09.011
N
Neil P. Shah
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
348
Papers
14.7K
Citations
51
h-index
139
i10-index
Neil P. Shah is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Acute Myeloid Leukemia Research. The author has an h-index of 51, co-authored 296 publications.
ORCID: 0000-0003-4398-3388Papers by this author
worksAssessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia
2020 · JAMA Oncology · 101 citations
https://doi.org/10.1001/jamaoncol.2020.5774
Six-Month Outcomes of Mechanical Thrombectomy for Treating Deep Vein Thrombosis: Analysis from the 500-Patient CLOUT Registry
2023 · CardioVascular and Interventional Radiology · 32 citations
https://doi.org/10.1007/s00270-023-03509-8
Characterization of the <i>BCR</i> Promoter in Philadelphia Chromosome-Positive and -Negative Cell Lines
1991 · Molecular and Cellular Biology · 31 citations
https://doi.org/10.1128/mcb.11.4.1854-1860.1991
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
2024 · Leukemia · 30 citations
https://doi.org/10.1038/s41375-024-02159-0
Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies
2013 · Cancer Chemotherapy and Pharmacology · 28 citations
https://doi.org/10.1007/s00280-013-2160-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat